ANNA READ: Open Payments
NPI 1376314229 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $698 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $216 |
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| PFIZER INC. | 5 | $81 |
| Lilly USA, LLC | 4 | $65 |
| Novo Nordisk Inc | 3 | $55 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
Products named: VRAYLAR, QULIPTA, MOUNJARO, PREVNAR 20, UBRELVY, Ozempic, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across IA — which companies pay providers there.
